Metraipolis › archive › dc_f06e6220df3d

Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety — Europe PMC PMID:42292432

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292432
DOI
10.3389/fimmu.2026.1762151
License (as archived)
solo-consultazione
Archived
2026-11-01T05:04:11.331Z
SHA-256 of the archived text
0041fc5967b8109ffc41482b714d4720b6a5c87020defea5a1eeddc307a1ed33
Stable URL of this page
https://metraipolis.com/documento/dc_f06e6220df3d

How to cite

Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety — Europe PMC PMID:42292432 — Europe PMC (en), https://europepmc.org/article/MED/42292432 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f06e6220df3d (Metraipolis archive dc_f06e6220df3d, sha256 0041fc5967b8109ffc41482b714d4720b6a5c87020defea5a1eeddc307a1ed33)
BibTeX
@misc{dcf06e6220df3d,
  title = {Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety — Europe PMC PMID:42292432},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292432},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f06e6220df3d; sha256 0041fc5967b8109ffc41482b714d4720b6a5c87020defea5a1eeddc307a1ed33},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292432. Agents can read the archived copy with the MCP tool read_document.